Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQ: LMRI · Real-Time Price · USD
16.68
-1.05 (-5.92%)
Jan 9, 2026, 4:00 PM EST - Market closed
Company Description
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services.
The company was founded in 2018 and is based in Raleigh, North Carolina.
Lumexa Imaging Holdings, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Dec 11, 2025 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 4,200 |
| CEO | Caitlin Zulla |
Contact Details
Address: 4200 Six Forks Road, Suite 1000 Raleigh, North Carolina 27609 United States | |
| Phone | 919 763 1100 |
| Website | lumexaimaging.com |
Stock Details
| Ticker Symbol | LMRI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.50 |
| CIK Code | 2071288 |
| CUSIP Number | 550249106 |
| ISIN Number | US5502491062 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Caitlin Zulla | Chief Executive Officer |
| Tony Martin | Chief Financial Officer |
| Dr. Russell Stewart | Chief Medical Officer |
| Julie Szeker | Chief Legal Officer and Corporate Secretary |
| Lee Cooper | Chair of the Board |
| Molly Joseph | Lead Independent Director |
| Brett Brodnax | Director |
| Glenn Eisenberg | Director |
| Bridget Karlin | Director |
| Dr. Matthew Lungren | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 18, 2025 | 8-K | Current Report |
| Dec 12, 2025 | 8-K | Current Report |
| Dec 12, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Dec 12, 2025 | 424B4 | Prospectus |
| Dec 11, 2025 | CERT | Certification by an exchange approving securities for listing |
| Dec 11, 2025 | 8-A12B | Registration of securities |
| Dec 10, 2025 | EFFECT | Notice of Effectiveness |
| Dec 2, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 17, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Oct 10, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |